A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors

NCT00682279 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Cancelled before enrollment

Conditions

Advanced Solid Tumors

Interventions

DRUG: oral topotecan (SK&F-104864); lapatinib (GW572016)

Sponsor

GlaxoSmithKline